Astrazeneca plc Net Tangible Assets

Astrazeneca plc (AZN) currently reports a net tangible assets of $49B as of December 2025. That compares with $41B in the prior-year period — up 19.2% year over year. Use the charts on this page to explore Astrazeneca plc's net tangible assets history and peer comparisons.

Astrazeneca plc's net tangible assets increased from $41B to $49B — a 19.2% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Astrazeneca plc reported $49B in net tangible assets as of December 2025. That compares with $41B in the prior-year period — up 19.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $49B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Astrazeneca plc, and consider following AZN for alerts when major investors trade the stock.

Astrazeneca plc is classified in the Healthcare sector. On net tangible assets, it currently shows $49B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AZN with unrelated industries.